Searched over 200M research papers
10 papers analyzed
Some studies suggest elevated copper levels in blood are associated with depressive disorder, hematological malignancies, and diabetes, while other studies indicate they may play a protective role against coronary artery disease and systolic blood pressure.
20 papers analyzed
Elevated copper levels in the blood have been linked to various mental health conditions. A systematic review and meta-analysis found that patients with depressive disorders had higher blood copper levels compared to controls without depression, suggesting that copper might serve as a biomarker for depression. Additionally, elevated copper levels have been associated with adverse cognitive effects. In schoolchildren, higher copper levels were linked to poorer working memory, particularly in boys, indicating that excess copper can negatively impact cognitive development.
The relationship between blood copper levels and cardiometabolic diseases has been explored with mixed findings. Observational studies have linked higher blood copper levels with an increased risk of cardiovascular diseases. However, a Mendelian randomization study suggested that genetically higher copper levels might actually play a protective role against coronary artery disease (CAD) and lower systolic blood pressure, challenging previous observational evidence.
Elevated copper levels are also observed in patients with hematological malignancies. Studies have shown that patients with relapsing or progressive hematological diseases have higher serum copper levels compared to those in remission or with stable disease . This suggests that copper levels could potentially be used to monitor disease progression and remission in hematological conditions.
Copper's role in diabetes mellitus (DM) has been investigated, with findings indicating that DM patients have higher plasma and serum copper levels compared to healthy individuals. This association is consistent across both type 1 and type 2 diabetes, as well as in patients with and without complications. The elevated copper levels in DM patients are thought to be linked to oxidative stress, which plays a role in the onset and progression of the disease.
Elevated copper levels have been reported in various other pathological conditions, including congestive cardiac failure, pneumonia, and several inflammatory diseases. However, the diagnostic value of copper levels in these conditions remains uncertain due to inconsistencies in the data.
The use of combination oral contraceptives (COCs) has been shown to elevate serum copper levels. A meta-analysis found that COC users had significantly higher copper levels compared to non-users, with levels often exceeding the normal reference range. While these elevated levels are not considered toxic, there are concerns about potential oxidative stress-related effects.
Elevated copper levels in the blood are associated with a range of health conditions, including mental health disorders, cardiometabolic diseases, hematological malignancies, and diabetes mellitus. While elevated copper can serve as a biomarker for certain conditions, its role in disease progression and its potential protective effects in some cases warrant further investigation. Understanding the implications of elevated copper levels can aid in the development of diagnostic and therapeutic strategies for various diseases.
Most relevant research papers on this topic